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Background
The incidence of abdominal aortic aneurysms (AAAs) has
increased in western societies and complications often
lead to life threatening events. There is still controversy
regarding the management of medium sized AAAs. There-
fore, novel biomarkers, besides aneurysmal diameter, are
needed to assess aortic wall integrity and risk of rupture.
Elastin is the key protein for maintaining stability of the
aortic and aneurysmal wall. Elastin degradation due to
inflammation and metalloproteinases (MMPs) expression
as well as de novo synthesis of immature elastin are
considered key events in the development of AAAs.
The aim of this study was to test a novel small-
molecular-weight elastin-specific MR probe for the in
vivo assessment of arterial wall integrity in AAAs.
Methods
ApoE-/- mice were infused with angiotensin II for up to
4 weeks (1000ng/kg/min). An elastin-specific MR probe
(Lantheus Medical Imaging, USA) was administered 1-4
weeks following Ang-II infusion. Mice were scanned at
each time point pre, post control agent (Gd-DTPA) and
after administration of the elastin-specific probe. Imaging
was performed using a 3T Philips Achieva MR scanner
with mice positioned on top of a microscopy coil. For the
assessment of contrast agent distribution, delayed enhance-
ment (DE) MRI scans were preceded by a 2D-Look-Locker
to determine the optimal inversion time for blood signal
nulling. Imaging parameters of the IR-3D GE DE-MRI
were: FOV=30mm, matrix=300, spatial resolution=0.1,
0.5mm slice thickness, TR/TE=28/8.2ms, TR between IR
pulses=1000ms and flip angle=30°. Immediately after the
DE-MRI scan, a 3D-T1 mapping sequence was performed,
consisting of 2 inversion-recovery prepared modified Look-
Locker trains. Aneurysmal aortic wall samples were
analysed ex vivo by inductively coupled plasma mass spec-
troscopy and histological staining.
Results
The high signal provided by the elastin-specific MR probe
allowed for imaging with high spatial resolution (100μm).
In vivo AAA area measurements were in good agreement
(R2=0.95, p<0.05, Fig. 1) with ex vivo measurement on
histology (ElasticavanGiesson stain, Fig. 1). Contrast-to-
noise-ratios (CNR) and R1 relaxation rates were in good
agreement with ex vivo histomorphometry (Elastica stain,
R2=0.77, p<0.05) and Gd concentrations determined by
inductively coupled plasma mass spectroscopy (R2=0.74,
p<0.05). Changes in elastin content could be readily
delineated and quantified at different stages of AAAs. The
most significant increase in elastin accumulation was
observed in late stage aortic aneurysms (Fig. 2) and is likely
related to compensatory remodeling and de novo synthesis
of elastin fibers.
Conclusions
MRI in combination with an elastin-specific MR probe
offers potential for the non-invasive characterisation of the
aneurysmal aortic wall during development of AAAs and
may help guiding treatment decisions.
1Division of Imaging Sciences, King’s College London, London, UK
Full list of author information is available at the end of the article
Makowski et al. Journal of Cardiovascular Magnetic
Resonance 2013, 15(Suppl 1):O4
http://www.jcmr-online.com/content/15/S1/O4
© 2013 Makowski et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Figure 1 In vivo and ex vivo assessment of AAA area. A: TOF-angiogram (A1) of the suprarenal part of the abdominal aorta 4 weeks after infusion
of saline in an ApoE-/- mouse (sham, control). The red line indicates the imaging plane. A non-dilated aortic lumen was found on the angiogram
and elastin MRI scan (A4, A5). B: Angiogram (B1) of the suprarenal part of the abdominal aorta 4 weeks after the infusion of angiotensin II in an
ApoE-/- mouse (4 week group). On the TOF, a large suprarenal aortic aneurysm could be clearly visualized. On Elastin-MRI a significantly enlarged
aortic lumen and a strong enhancement of the aortic wall was visualized (B4, B5). No significant enhancement of the aortic wall could be measured
after administration of nonspecific Gd-DTPA. C: A significant increase in aortic vessel wall area was observed over the 4-week time course of
angiotensin II infusion. D: In vivo area measurements of lumen area on elastin MRI scans significantly correlated with ex vivo measurements on
histology.
Figure 2 In vivo assessment of advanced thrombus remodeling. A: TOF-angiogram of the suprarenal part of the abdominal aorta (A1, A2 fusion with
Elastin-MRI scan) 4 weeks after infusion of angiotensin II. On the TOF angiogram the formation of a large aortic aneurysm can be observed. At this late
stage the thrombus in the aneurysmal wall is almost completely remodelled with elastin (A6, A11). The locations of rupture of the elastic laminae are
still visible (A11, magnification on right side, red arrows). A “novel elastic lamina” is formed on the luminal side of the arterial wall (A11, magnification
on left side, red arrow heads). A strong signal can be observed in the area of remodeling on Elastin-MRI (A3-5, A8-10, red arrows). B: Example of a T1
relaxation curve prior to and after administration of the elastin-specific MR imaging probe. A significant shortening of the T1 relaxation time could be
measured post injection of the elastin-specific MR imaging probe.
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